Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yingming Li

Showing results (181-190 of 188) with videos related to

Pageof 19
Sort By:
You have reached the last page of results.This site can display upto 188 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 26, 2026
Evolution of AR and non-AR alterations in circulating tumor DNA of metastatic prostate cancer patients treated in the phase 3 Alliance A031201 trialJosé C Valentín López, Chenxi Yu, Todd P Knutson, et al.
Nature Communications|November 30, 2016
Truncation and constitutive activation of the androgen receptor by diverse genomic rearrangements in prostate cancerChristine Henzler, Yingming Li, Rendong Yang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 15, 2020
Diverse <i>AR</i> Gene Rearrangements Mediate Resistance to Androgen Receptor Inhibitors in Metastatic Prostate CancerYingming Li, Rendong Yang, Christine M Henzler, et al.
Nature Communications|March 20, 2026
Tumor-specific lncRNA IGF1R-AS1 trans-regulates chromatin interactions associated with oncogenic MYC signalingYongyong Yang, Ting-You Wang, Joshua Fry, et al.
Cancer Immunology Research|November 15, 2024
A PSMA-Targeted Tri-Specific Killer Engager Enhances NK Cell Cytotoxicity against Prostate CancerShee Kwan Phung, Nicholas A Zorko, Yvette Soignier, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 6, 2017
Androgen Receptor Variant AR-V9 Is Coexpressed with AR-V7 in Prostate Cancer Metastases and Predicts Abiraterone ResistanceManish Kohli, Yeung Ho, David W Hillman, et al.
Journal of Environmental Sciences (China)|December 29, 2025
Breakthroughs in new pollutant research: Analytical methods, environmental processes, toxicological mechanisms, and control strategiesLu Jiang, Yali Shi, Lu Bai, et al.
European Urology|July 28, 2018
Patient-derived Models of Abiraterone- and Enzalutamide-resistant Prostate Cancer Reveal Sensitivity to Ribosome-directed TherapyMitchell G Lawrence, Daisuke Obinata, Shahneen Sandhu, et al.
Pageof 19

Showing results (181-190 of 188) with videos related to

Sort By:
Pageof 19
You have reached the last page of results.This site can display upto 188 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 26, 2026
Evolution of AR and non-AR alterations in circulating tumor DNA of metastatic prostate cancer patients treated in the phase 3 Alliance A031201 trialJosé C Valentín López, Chenxi Yu, Todd P Knutson, et al.
Nature Communications|November 30, 2016
Truncation and constitutive activation of the androgen receptor by diverse genomic rearrangements in prostate cancerChristine Henzler, Yingming Li, Rendong Yang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 15, 2020
Diverse <i>AR</i> Gene Rearrangements Mediate Resistance to Androgen Receptor Inhibitors in Metastatic Prostate CancerYingming Li, Rendong Yang, Christine M Henzler, et al.
Nature Communications|March 20, 2026
Tumor-specific lncRNA IGF1R-AS1 trans-regulates chromatin interactions associated with oncogenic MYC signalingYongyong Yang, Ting-You Wang, Joshua Fry, et al.
Cancer Immunology Research|November 15, 2024
A PSMA-Targeted Tri-Specific Killer Engager Enhances NK Cell Cytotoxicity against Prostate CancerShee Kwan Phung, Nicholas A Zorko, Yvette Soignier, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 6, 2017
Androgen Receptor Variant AR-V9 Is Coexpressed with AR-V7 in Prostate Cancer Metastases and Predicts Abiraterone ResistanceManish Kohli, Yeung Ho, David W Hillman, et al.
Journal of Environmental Sciences (China)|December 29, 2025
Breakthroughs in new pollutant research: Analytical methods, environmental processes, toxicological mechanisms, and control strategiesLu Jiang, Yali Shi, Lu Bai, et al.
European Urology|July 28, 2018
Patient-derived Models of Abiraterone- and Enzalutamide-resistant Prostate Cancer Reveal Sensitivity to Ribosome-directed TherapyMitchell G Lawrence, Daisuke Obinata, Shahneen Sandhu, et al.
Pageof 19